000 01553 a2200421 4500
005 20250517133320.0
264 0 _c20170508
008 201705s 0 0 eng d
022 _a1476-5462
024 7 _a10.1038/gt.2017.3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMølgaard, K
245 0 0 _aBalanced secretion of anti-CEA × anti-CD3 diabody chains using the 2A self-cleaving peptide maximizes diabody assembly and tumor-specific cytotoxicity.
_h[electronic resource]
260 _bGene therapy
_c04 2017
300 _a208-214 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntibodies, Bispecific
_xgenetics
650 0 4 _aCD3 Complex
_xgenetics
650 0 4 _aCarcinoembryonic Antigen
_ximmunology
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aFoot-and-Mouth Disease Virus
_xgenetics
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aJurkat Cells
650 0 4 _aLymphocyte Activation
_ximmunology
650 0 4 _aNeoplasms
_ximmunology
650 0 4 _aPeptides
_xgenetics
650 0 4 _aSingle-Chain Antibodies
_xgenetics
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aTumor Necrosis Factor Receptor Superfamily, Member 7
_xgenetics
700 1 _aCompte, M
700 1 _aNuñez-Prado, N
700 1 _aHarwood, S L
700 1 _aSanz, L
700 1 _aAlvarez-Vallina, L
773 0 _tGene therapy
_gvol. 24
_gno. 4
_gp. 208-214
856 4 0 _uhttps://doi.org/10.1038/gt.2017.3
_zAvailable from publisher's website
999 _c26773043
_d26773043